IFN-α 2a, human recombinant
Interferon-alpha 2a (IFN-alpha 2a) is a Type I interferon made by leukocytes during viral infection. It has anti-viral and non-proliferative activity induced by JAK1-STAT signaling. IFN-alpha 2s are the most widely used type for therapeutic purposes. IFN-alpha 2b is a variant of IFNα 2a that differs by one amino acid. Recombinant human IFNα 2a is a non-glycosylated protein.
Peptides & proteins
Type I Interferon, Alpha 2
at -20°C
at least 12 months
NAME: Interferon-alpha 2a; ACCESSION/UNIPROT#: P01563; EXPRESSION SYSTEM: E.coli; FORMAT: Lyophilized from a sterile (0.2 micron) filtered aqueous solution containing 0.1% Trifluoroacetic Acid (TFA). Reconstitute in sterile water at 0.1 mg/mL.; TESTING: Viral CPE assay using EMC virus on A549 cells with an acceptance criteria of 2.0 x 10^8 units/mg.; #AA: 166; SEQUENCE: MCDLPQTHSL GSRRTLMLLA QMRKISLFSC LKDRHDFGFP QEEFGNQFQK AETIPVLHEM IQQIFNLFST KDSSAAWDET LLDKFYTELY QQLNDLEACV IQGVGVTETP LMKEDSILAV RKYFQRITLY LKEKKYSPCA WEVVRAEIMR SFSLSTNLQE SLRSKE